http://purl.uniprot.org/citations/22350467 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/22350467 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundRenal interstitial fibrosis is the common pathway in progressive renal diseases, where oxidative stress promotes inflammation and macrophage infiltration. Febuxostat is a novel nonpurine xanthine oxidase (XO)-specific inhibitor for treating hyperuricemia. While some reports suggest a relationship between hyperuricemia and chronic kidney disease (CKD), the renoprotective mechanism of an XO inhibitor in CKD remains unknown. Recent reports have focused on XO as a source of oxidative stress.MethodsHere, we investigate the potential of febuxostat to reduce fibrogenic and inflammatory responses in an established interstitial fibrosis model-unilateral ureteric obstruction (UUO). Male Sprague-Dawley rats were divided into three groups: sham-operated group, vehicle-treated UUO group, and febuxostat-treated UUO group.ResultsTreatment with febuxostat diminished XO activity in obstructed kidneys, and suppressed nitrotyrosine, a marker of oxidative stress. Consequently, febuxostat inhibited early proinflammatory cytokine expression, followed by a reduction of interstitial macrophage infiltration. In addition, febuxostat suppressed transforming growth factor-β messenger RNA expression, thereby ameliorating smooth muscle alpha actin and type I collagen expression.ConclusionOur results provide evidence for the renoprotective action of febuxostat against the formation of interstitial fibrosis. A decrease in macrophage infiltration and interstitial fibrosis, along with a decrease of the oxidative stress marker, strongly suggests the existence of a causal relationship between them. Febuxostat may have therapeutic value in slowing or preventing interstitial fibrosis in patients with CKD."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.org/dc/terms/identifier | "doi:10.1007/s10157-012-0609-3"xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Inoue K."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Ueda Y."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Omori H."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Matsui I."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Moriyama T."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Yamamoto R."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Kawada N."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Isaka Y."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Rakugi H."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Takabatake Y."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/author | "Kaimori J."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/date | "2012"xsd:gYear |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/name | "Clin Exp Nephrol"xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/pages | "549-556"xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/title | "Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy."xsd:string |
http://purl.uniprot.org/citations/22350467 | http://purl.uniprot.org/core/volume | "16"xsd:string |
http://purl.uniprot.org/citations/22350467 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/22350467 |
http://purl.uniprot.org/citations/22350467 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/22350467 |
http://purl.uniprot.org/uniprot/#_A0A8I5Y0Y5-mappedCitation-22350467 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22350467 |
http://purl.uniprot.org/uniprot/#_A0A8I5ZPE7-mappedCitation-22350467 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22350467 |
http://purl.uniprot.org/uniprot/#_F1LQS6-mappedCitation-22350467 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22350467 |
http://purl.uniprot.org/uniprot/#_P22985-mappedCitation-22350467 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22350467 |